Short-term stimulation with histone deacetylase inhibitor trichostatin a induces epithelial-mesenchymal transition in nasopharyngeal carcinoma cells without increasing cell invasion ability
- PMID: 30902084
- PMCID: PMC6431036
- DOI: 10.1186/s12885-019-5482-y
Short-term stimulation with histone deacetylase inhibitor trichostatin a induces epithelial-mesenchymal transition in nasopharyngeal carcinoma cells without increasing cell invasion ability
Abstract
Background: Epithelial-mesenchymal transition (EMT) may be one of the reasons for the failure in some clinical trials regarding histone deacetylase inhibitors (HDACIs)-treated solid tumors. We investigated the effects of a pan-HDACI trichostatin A (TSA) on the proliferation and EMT of nasopharyngeal carcinoma (NPC) cells.
Methods: Poorly-differentiated NPC cell line CNE2 and undifferentiated C666-1 were treated with various concentrations of TSA, the cell viability was assessed by CCK-8 assay, the morphology was photographed, and the mRNA level of HDACs was assessed by semiquantitative PCR. After determination the cell cycle distributions, cells were subjected to western blotting analysis of cell cycle and EMT-associated genes expression. And the changes in migration ability were assessed by transwell migration assay and scratch wound healing assay. Finally, histone deacetylases activator ITSA-1 was used to assess the reverse of TSA-induced changes in NPC cells.
Results: TSA inhibited the proliferation of CNE2 and C666-1 cells in a concentration-dependent manner and arrested the cell cycle at G1 phases. TSA reduced PCNA, cyclin D1, cyclin E1, CDK2, p16 and p21 expressions and stimulated CDK6 levels. TSA stimulation for 48 h could effectively induce the EMT in CNE2 and C666-1 cells, which showed an increase of spindle-like cells and promoted expression of Vimentin and Snail1 expression in a concentration-dependent manner. Surprisingly, this short period of TSA treatment that induced EMT also impeded the migration ability of CNE2 and C666-1 cells. Interestingly, ITSA-1 rescued TSA-impeded CNE2 and C666-1 cells' proliferation, migration and HDACs expression, also re-induced the cells to turn into epithelial cell phenotypes.
Conclusions: These results indicate that short-term stimulation of TSA effectively inhibits cell proliferation and induce EMT-like changes in NPC cells but not increase its invasion ability.
Keywords: Epithelial mesenchymal transition; Histone deacetylase inhibitor; ITSA-1; Migration; Nasopharyngeal carcinoma; Proliferation; Trichostatin a.
Conflict of interest statement
Ethics approval and consent to participate
All usage of cell lines did not require Ethic approval.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Trichostatin A promotes esophageal squamous cell carcinoma cell migration and EMT through BRD4/ERK1/2-dependent pathway.Cancer Med. 2021 Aug;10(15):5235-5245. doi: 10.1002/cam4.4059. Epub 2021 Jun 23. Cancer Med. 2021. PMID: 34160902 Free PMC article.
-
[Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism].Mol Biol (Mosk). 2018 May-Jun;52(3):474-481. doi: 10.7868/S0026898418030102. Mol Biol (Mosk). 2018. PMID: 29989579 Russian.
-
HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells.Oncol Rep. 2015 May;33(5):2299-308. doi: 10.3892/or.2015.3879. Epub 2015 Mar 23. Oncol Rep. 2015. PMID: 25813246
-
Trichostatin A, a histone deacetylase inhibitor, reverses epithelial-mesenchymal transition in colorectal cancer SW480 and prostate cancer PC3 cells.Biochem Biophys Res Commun. 2015 Jan 2;456(1):320-6. doi: 10.1016/j.bbrc.2014.11.079. Epub 2014 Nov 28. Biochem Biophys Res Commun. 2015. PMID: 25434997
-
Histone deacetylase inhibitors trichostatin A and vorinostat inhibit TGFβ2-induced lens epithelial-to-mesenchymal cell transition.Invest Ophthalmol Vis Sci. 2014 Jul 3;55(8):4731-40. doi: 10.1167/iovs.14-14109. Invest Ophthalmol Vis Sci. 2014. PMID: 24994865
Cited by
-
Post-translational protein lactylation modification in health and diseases: a double-edged sword.J Transl Med. 2024 Jan 10;22(1):41. doi: 10.1186/s12967-023-04842-9. J Transl Med. 2024. PMID: 38200523 Free PMC article. Review.
-
Butyrate-mediated Resistance to Trichostatin A Accompanied by Elevated Expression of Glucose Transporter 3 (GLUT3) in Human Colorectal Carcinoma HCT116 Cells.Asian Pac J Cancer Prev. 2023 Dec 1;24(12):4085-4092. doi: 10.31557/APJCP.2023.24.12.4085. Asian Pac J Cancer Prev. 2023. PMID: 38156841 Free PMC article.
-
Human bone marrow mesenchymal stem cell-derived extracellular vesicles reduce inflammation and pyroptosis in acute kidney injury via miR-223-3p/HDAC2/SNRK.Inflamm Res. 2023 Mar;72(3):553-576. doi: 10.1007/s00011-022-01653-4. Epub 2023 Jan 14. Inflamm Res. 2023. PMID: 36640195 Free PMC article.
-
Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review.Pharmaceuticals (Basel). 2022 Oct 8;15(10):1235. doi: 10.3390/ph15101235. Pharmaceuticals (Basel). 2022. PMID: 36297347 Free PMC article. Review.
-
Trichostatin A inhibits dendritic cell maturation through down-regulating NF-κ B (p65) pathway.Mol Biol Rep. 2022 Apr;49(4):2619-2627. doi: 10.1007/s11033-021-07065-7. Epub 2022 Jan 14. Mol Biol Rep. 2022. PMID: 35028853
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous